Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial-Reference-Cited by-同舟云学术

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

Published:2007-03 Issue:9564 Volume:369 Page:836-843
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Nadel Simon,Goldstein Brahm,Williams Mark D,Dalton Heidi,Peters Mark,Macias William L,Abd-Allah Shamel A,Levy Howard,Angle Robinette,Wang Dazhe,Sundin David P,Giroir Brett

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Advances in the therapy for sepsis in children;Anderson;Pediatr Clin North Am,1997

2. Septic shock;Butt;Pediatr Clin North Am,2001

4. Sepsis in neonates and children: definitions, epidemiology, and outcome;Martinot;Pediatr Emerg Care,1997

5. The epidemiology of severe sepsis in children in the United States;Watson;Am J Respir Crit Care Med,2003

Cited by 429 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Clinical Characteristics of Viral and Bacterial Sepsis in Children: a Single-Center Retrospective Analysis;Journal of Pediatric Intensive Care;2024-08-23

2. Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes;Critical Care;2024-07-17

3. Vascular leak in sepsis: physiological basis and potential therapeutic advances;Critical Care;2024-03-23

4. Sepsis - associated disseminated intravascular coagulation - a constant problem of the present;Vnitřní lékařství;2023-12-18

5. New plasma protein C and protein S concentrate: A synergy for therapeutic purposes;Vox Sanguinis;2023-11-28